Fluticasone furoate will reach the US OTC market as Flonase Sensimist Allergy Relief following FDA's recent FDA approval of GlaxoSmithKline PLC's supplemental new drug application to market its previously Rx product Veramyst (fluticasone furoate/0.0275mg metered spray) over-the counter.
GSK's Flonase Sensimist (Veramyst) Switches Name On Way To OTC
GSK gains approval of sNDA for Rx Veramyst (fluticasone furoate/spray) to be marketed OTC as Flonase Sensimist, an extension of the Flonase Allergy Relief.